Inventor
ROBERT F. ROSCOW
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C12NMicroorganisms or enzymes6%
PatentTitleYear
12,569,466Short-acting psychoactive compounds of the MDMA class202612,570,621Short-acting 3,4-methylenedioxymethamphetamine (MDMA) analogs incorporating benzothiazole202612,064,415Psilocin prodrug compounds and methods of synthesizing the same202411,952,342Aza-substituted psilocin analogs and methods of synthesizing the same202411,939,292Aza-substituted psilocin analogs and methods of synthesizing the same202411,896,577Short-acting psychoactive compounds of the MDMA class202411,466,283Plants and methods for increasing and decreasing synthesis of cannabinoids2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to CANOPY GROWTH CORP (1)· patent assignee history
2022–2026Based in US· patent location history
2024–2026Patents assigned to MYDECINE INNOVATIONS GROUP INC (6)· patent assignee history
2026Patents assigned to APOAPSIS HOLDINGS LLC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MYDECINE INNOVATIONS GROUP INC | 6 | 2024–2026 |
| APOAPSIS HOLDINGS LLC | 2 | 2026 |
| CANOPY GROWTH CORP | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2026 |